Recently, a number of studies have reported that miR-340 plays a critical role in tumor initiation and progression, by targeting multiple oncogenes such as SKP2, FHL2, c-Met, and ROCK1 (Table 1). The gene discussed is SKP2; the disease is neoplasm.